These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 27432767

  • 1. Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China.
    Fan X, Xiao M, Chen S, Kong F, Dou HT, Wang H, Xiao YL, Kang M, Sun ZY, Hu ZD, Wan Z, Chen SL, Liao K, Chu YZ, Hu TS, Zou GL, Hou X, Zhang L, Zhao YP, Xu YC, Liu ZY.
    Clin Microbiol Infect; 2016 Oct; 22(10):887.e1-887.e9. PubMed ID: 27432767
    [Abstract] [Full Text] [Related]

  • 2. Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
    Yang JH, Huang PY, Cheng CW, Shie SS, Lin ZF, Yang LY, Lee CH, Wu TS.
    Med Mycol; 2021 Nov 03; 59(11):1114-1121. PubMed ID: 34374784
    [Abstract] [Full Text] [Related]

  • 3. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F, Hare Jensen R, Meis JF, Arendrup MC.
    Mycoses; 2016 Sep 03; 59(9):576-84. PubMed ID: 27061834
    [Abstract] [Full Text] [Related]

  • 4. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R, Fuchs V, Graf B, Hamprecht A, Hogardt M, Sedlacek L, Schwarz R, Idelevich EA, Becker SL, Held J, Küpper-Tetzel CP, McCormick-Smith I, Heckmann D, Gerkrath J, Han CO, Wilmes D, Rickerts V.
    Int J Med Microbiol; 2019 Sep 03; 309(6):151336. PubMed ID: 31444102
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the Cryptococcus neoformans Complex in Jiangxi Province, South Central China.
    Yang C, Bian Z, Blechert O, Deng F, Chen H, Li Y, Yang Y, Chen M, Zhan P.
    Front Cell Infect Microbiol; 2021 Sep 03; 11():723251. PubMed ID: 34790585
    [Abstract] [Full Text] [Related]

  • 8. Genotypic diversity and antifungal susceptibility of environmental isolates of Cryptococcus neoformans from the Yangtze River Delta region of East China.
    Chen M, Wang Y, Li Y, Hong N, Zhu X, Pan W, Liao W, Xu J, Du J, Chen J.
    Med Mycol; 2021 Jul 06; 59(7):653-663. PubMed ID: 33269400
    [Abstract] [Full Text] [Related]

  • 9. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK, Souza Junior AH, Costa CR, Faganello J, Vainstein MH, Chagas AL, Souza AC, Silva MR.
    Mycoses; 2010 Jan 06; 53(1):62-7. PubMed ID: 19500261
    [Abstract] [Full Text] [Related]

  • 10. Molecular characterization of Cryptococcus neoformans isolated from the environment in Beijing, China.
    Dou H, Wang H, Xie S, Chen X, Xu Z, Xu Y.
    Med Mycol; 2017 Oct 01; 55(7):737-747. PubMed ID: 28431114
    [Abstract] [Full Text] [Related]

  • 11. Molecular epidemiology of Italian clinical Cryptococcus neoformans var. grubii isolates.
    Cogliati M, Zamfirova RR, Tortorano AM, Viviani MA, Fimua Cryptococcosis Network.
    Med Mycol; 2013 Jul 01; 51(5):499-506. PubMed ID: 23286351
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
    Bertout S, Drakulovski P, Kouanfack C, Krasteva D, Ngouana T, Dunyach-Rémy C, Dongtsa J, Aghokeng A, Delaporte E, Koulla-Shiro S, Reynes J, Mallié M.
    Clin Microbiol Infect; 2013 Aug 01; 19(8):763-9. PubMed ID: 23033854
    [Abstract] [Full Text] [Related]

  • 15. Molecular typing of clinical Cryptococcus neoformans isolates collected in Germany from 2004 to 2010.
    Sanchini A, Smith IM, Sedlacek L, Schwarz R, Tintelnot K, Rickerts V.
    Med Microbiol Immunol; 2014 Oct 01; 203(5):333-40. PubMed ID: 24838744
    [Abstract] [Full Text] [Related]

  • 16. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ, Wu HC, Hsueh PR.
    Clin Microbiol Infect; 2010 Jun 01; 16(6):696-703. PubMed ID: 19694765
    [Abstract] [Full Text] [Related]

  • 17. Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China.
    Hong N, Chen M, Xu N, Al-Hatmi AMS, Zhang C, Pan WH, Hagen F, Boekhout T, Xu J, Zou XB, Liao WQ.
    Mycoses; 2019 Feb 01; 62(2):171-180. PubMed ID: 30341799
    [Abstract] [Full Text] [Related]

  • 18. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA, Arthur I, Merritt A, Leung M.
    Med Mycol; 2019 Nov 01; 57(8):1004-1010. PubMed ID: 30649538
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.